[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 580
Citations 0
Research Letter
November 7, 2019

Association of Rising Cost and Use of Oral Anticancer Drugs With Medicare Part D Spending From 2013 Through 2017

Author Affiliations
  • 1Harvard Medical School, Boston, Massachusetts
  • 2Harvard Business School, Boston, Massachusetts
  • 3Department of Dermatology, Brigham and Women’s Hospital, Boston, Massachusetts
  • 4Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts
JAMA Oncol. Published online November 7, 2019. doi:https://doi.org/10.1001/jamaoncol.2019.4906

Increased spending on oral anticancer drugs should ideally be driven by increased use because of rising access to care and expanding drug indications.1,2 Yet, prices have risen faster than inflation and are not necessarily reflective of novelty or efficacy.2,3 This study weighs the proportional associations of rising drug costs and use with increased Medicare Part D spending for a cohort of oral anticancer drugs used from 2013 through 2017.

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words